9ZG-20286-23072
4 vaccinations
6 coded responses
37 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 800 / CO
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-12
- 2021-02-18
- 2021-02-24
- 2021-03-03
- 2021-03-10
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Kidney infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Kidney infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
-
2021-09-05
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-03
-
2021-10-10
Survey response — day 35, dose 3MedDRA: Fatigue, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sneezing, fatigue, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-17
Survey response — day 42, dose 3MedDRA: Fatigue, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue, runny nose low grade feverMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Has COVIDMedDRA releases: 2024-11 · check-in free text available
- 2022-04-08
- 2022-09-05
-
2022-10-08
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-14
- 2022-10-15
- 2022-10-23
- 2022-10-31
- 2022-11-06
- 2022-11-12
- 2022-11-21
- 2023-01-07
-
2023-04-08
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-08
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-10
Call successfulDoes not wish to fill out VAERS report
-
2023-04-10
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-09-05 | Pfizer-BioNTech | No |
| 4 | 2022-10-08 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 successful
1 wait over 3 months for a first call
Free text
Release 8 — 3 months, dose 2
Symptoms: Kidney infection
Release 10 — day 35, dose 3
Symptoms: Sneezing, fatigue, runny nose
Release 10 — day 42, dose 3
Symptoms: Fatigue, runny nose low grade fever
Release 10 — 3 months, dose 3
Symptoms: Cold like symptoms
Release 11 — 6 months, dose 3
Symptoms: Has COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Kidney infection | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release